TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer: triple therapy shows promise after chemo fails
Disease control CompletedThis Phase 2 trial tested a combination of three treatments—local chemotherapy delivered via beads into the liver, a targeted drug called apatinib, and an immunotherapy (PD-1 antibody)—in 20 patients with advanced bile duct cancer that had worsened after standard first-line chemo…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pain combo eases liver cancer procedure recovery
Symptom relief CompletedThis study looked at whether a combination of two pain medicines (hydromorphone and flurbiprofen) could help control pain during and after a liver cancer treatment called TACE. 129 adults with intermediate-to-advanced liver cancer took part. The goal was to see if this approach c…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE4 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
AI model may personalize liver cancer care after surgery
Knowledge-focused CompletedThis study analyzed data from 1005 liver cancer patients to see who benefits from a treatment called TACE after surgery. Using machine learning, researchers aimed to predict individual patient outcomes. The goal is to help doctors decide whether to recommend TACE or just monitor …
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
CT scan clues may guide better liver cancer care
Knowledge-focused CompletedThis study looked at 324 adults with intermediate-stage liver cancer to see if CT scan features could predict how well they would respond to a combination treatment of targeted therapy and a procedure that blocks the tumor's blood supply. The goal was to find out if certain scan …
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC